| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $317.9M | — | +9.6% |
| Cost of Revenue | $177.6M | — | +6.3% |
| R&D Expense | $15.9M | — | -18.0% |
| SG&A Expense | $33.3M | — | -27.9% |
| Operating Income | $80.0M | — | +67.8% |
| Pre-tax Income | $27.3M | — | — |
| Income Tax | $3.1M | — | +224.0% |
| Net Income | $24.7M | — | +212.9% |
| EPS (Basic) | $0.29 | — | +190.0% |
| EPS (Diluted) | $0.28 | — | +180.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $317.8M | +35.1% | +70.1% |
| Total Assets | $1.65B | +6.6% | +29.0% |
| Total Liabilities | $1.02B | +6.1% | +33.5% |
| Stockholders' Equity | $529.3M | +10.3% | +57.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $43.2M | — | +25.4% |
| Capital Expenditures | $3.2M | — | -15.9% |
| Investing Cash Flow | -$15.9M | — | +40.8% |
| Financing Cash Flow | $64.2M | — | +1799.8% |
| Free Cash Flow | $40.0M | — | +30.5% |